These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26120981)

  • 1. [The effect of the succinic acid preparation on the dynamics of neurological and emotional disturbances in patients with dorsopathy].
    Stetsura YA; Sholomov II; Schukovsky NV; Salina EA; Likhacheva EB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):45-48. PubMed ID: 26120981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [SUBSTANTIATION OF INDICATIONS FOR BIOFEEDBACK THERAPY AND CYTOFLAVIN APPLICATION IN TREATMENT OF OSTEOCHONDROSIS NEUROLOGICAL COMPLICATIONS IN ELDERLY PATIENTS].
    Parfenov Y; Vasilevskaya M; Parfenov S; Sapozhnikov K; Kovalenko A; Zaplutanov V
    Georgian Med News; 2018 Oct; (283):89-96. PubMed ID: 30516501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of cytoflavin for the treatment of chronic brucellosis].
    Shul'diakov AA; Liapina EP; Soboleva LA; Reshetnikov AA; Zubareva EV; Trubetskov AD; Anashchenko AV; Evdokimov AV
    Klin Med (Mosk); 2011; 89(2):56-8. PubMed ID: 21574446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of alcohol addiction syndrome with cytoflavin].
    Belov VG; Parfenov IuA; Okovityĭ SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6 Pt 2):54-7. PubMed ID: 23887469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin].
    Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy of cytoflavin used for the correction of psychoemotional and neuroimmune disturbances in the patients presenting with eczema].
    Laseev DI; Dikova OV
    Klin Med (Mosk); 2012; 90(2):50-3. PubMed ID: 22645963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroprotective effect of cytoflavin in closed craniocerebral trauma].
    Bul'on VV; Zarubina IV; Kovalenko AL; Alekseeva LE; Sapronov NS
    Eksp Klin Farmakol; 2003; 66(6):56-8. PubMed ID: 14743715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficiency of cytoflavin and ozonotherapy in complex treatment of the myasthenia].
    Drozd OA; Efremov VV; Dudarev IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):46-9. PubMed ID: 23528494
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of cytoflavin in patients in the acute ischemic stroke].
    Odinak MM; Skvortsova VI; Vozniuk IA; Rumiantseva SA; Stakhovskaia LV; Klocheva EG; Novikova LB; Ianishevskiĭ SN; Golokhvastov SIu; Tsygan NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):29-36. PubMed ID: 21311484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy of cytoflavin in the treatment of burnout syndrome].
    Chutko LS; Surushkina SY; Yakovenko EA; Rozhkova AV; Anisimova TI; Bondarchuk YL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):66-70. PubMed ID: 26525625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of cytoflavin in the complex treatment of patients with tick-borne encephalitis].
    Selezneva AG; Petrova AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(7):68-9. PubMed ID: 23011438
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytoflavin in the detoxification of alcohol-dependent patients].
    Minko AI; Linskiĭ IV; Kuz'minov VN; Samoĭlova ES; Goloshchapov VV; Artemchuk KA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):35-40. PubMed ID: 23887449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correction of energy homeostasis in the acute period of concomitant brain injury].
    Nikonov VV; Pavlenko AIu; Beletskiĭ AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7):32-6. PubMed ID: 23994918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficiency of cytoflavin in the treatment of somatoform disorders].
    Chutko LS; Surushkina SY; Yakovenko EA; Anisimova TI; Prokopenko SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(1):21-24. PubMed ID: 28252599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Performance evaluation of integrated cytoprotective therapy of different duration in patients with cerebral infarction].
    Chichanovskaia LV; Tsukurova LA; Kovalenko AL; Nazarov MV; Lukin DI; Rumiantseva SA; Silina EV; Stupin VA; Nedorostkova TIu; Kabaeva EN; Eliseev EV
    Eksp Klin Farmakol; 2015; 78(1):21-6. PubMed ID: 25826870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytoflavin in polychemotherapy of breast cancer].
    Kashuro VA; Glushkov SI; Zheregelia SN
    Antibiot Khimioter; 2010; 55(7-8):30-3. PubMed ID: 21140562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of cytoflavin in the treatment of chronic cerebral ischemia].
    Suslina ZA; Klocheva EG; Piradov MA; Rumiantseva SA; Romantsov MG; Kovalenko AL
    Klin Med (Mosk); 2010; 88(3):50-3. PubMed ID: 20608066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern methods of energy homeostasis correction in elderly patients].
    Rumiantseva SA; Silina EV; Tsukurova LA; Stupin VA; Chichanovskaia LV; Nazarov MV; Kovalenko AL; Kabaeva EN
    Adv Gerontol; 2014; 27(4):746-52. PubMed ID: 25946854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improvement of speech discrimination with cytoflavin in patients with chronic sensorineural deafness].
    Zhuravskiĭ SG
    Vestn Otorinolaringol; 2010; (4):82-6. PubMed ID: 21105353
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of cytoflavin for correction of complications of myocardial infarction].
    Bul'on VV; Khnychenko LK; Sapronov NS; Kovalenko AL; Alekseeva LE
    Eksp Klin Farmakol; 2002; 65(1):27-9. PubMed ID: 12025779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.